COURTNEY PENN: Open Payments
NPI 1275202095 · NEWPORT NEWS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$367 in 13 payments from 5 companies in 2025. Trend: 2023 $627 · 2024 $210 · 2025 $367
Food & beverage: $367
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Lilly USA, LLC | 4 | $81 |
| Novo Nordisk Inc | 3 | $67 |
| GlaxoSmithKline, LLC. | 3 | $63 |
| Amgen Inc. | 2 | $32 |
Products named: AIRSUPRA, MOUNJARO, TRELEGY ELLIPTA, Ozempic, OTEZLA, REPATHA.
Industry payments across VA — which companies pay providers there.
